DNMT3B Gene

Last updated on: 04.07.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The DNMT3B gene (DNMT3B stands for "DNA Methyltransferase 3 Beta") is a protein-coding gene located on chromosome 20q11.2. Eight alternatively spliced transcript variants have been described. The full-length sequences of variants 4 and 5 have not been determined.

General informationThis section has been translated automatically.

The encoded protein, a DNA methyltransferase is required for genome-wide de novo methylation and essential for the establishment of DNA methylation patterns during development. The protein is mainly localized in the nucleus, and its expression is regulated by development. DNA methylation is coordinated with histone methylation. Isoforms 4 and 5 are probably non-functional due to deletion of two conserved methyltransferase motifs.

Clinical pictureThis section has been translated automatically.

CpG methylation is an epigenetic alteration important for embryonic development, imprinting, and X chromosome inactivation. Mutations in this gene cause

  • the ICF syndrome ("Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome 1)

and

  • facioscapulohumeral muscular dystrophy 4

LiteratureThis section has been translated automatically.

  1. Brown DC et al (1995) ICF syndrome (immunodeficiency, centromeric instability and facial anomalies): investigation of heterochromatin abnormalities and review of clinical outcome. Hum. Genet 96: 411-416.
  2. Fasth A et al. (1990) Fragility of the centromeric region of chromosome 1 associated with combined immunodeficiency in siblings: a recessively inherited entity? Acta Paediat Scand 79: 605-612.
  3. Haas OA etal. (1990) Centromeric heterochromatin instability of chromosomes 1, 9, and 16 in variable immunodeficiency syndrome--a virus-induced phenomenon? Hum Genet 85: 244-246.
  4. Jin B et al. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Hum Molec Genet 17: 690-709.
  5. Tiepolo L et al (1979) Multibranched chromosomes 1, 9 and 16 in a patient with combined IgA and IgE deficiency. Hum Genet 51: 127-137.
  6. Valkova G et al (1987) Centromeric instability of chromosomes 1, 9 and 16 with variable immune deficiency: support of a new syndrome. Clin Genet 31: 119-124.

Last updated on: 04.07.2022